130 related articles for article (PubMed ID: 10886205)
1. Captopril inhibits in vitro and in vivo the proliferation of primitive haematopoietic cells induced into cell cycle by cytotoxic drug administration or irradiation but has no effect on myeloid leukaemia cell proliferation.
Chisi JE; Briscoe CV; Ezan E; Genet R; Riches AC; Wdzieczak-Bakala J
Br J Haematol; 2000 Jun; 109(3):563-70. PubMed ID: 10886205
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory action of the peptide AcSDKP on the proliferative state of hematopoietic stem cells in the presence of captopril but not lisinopril.
Chisi JE; Wdzieczak-Bakala J; Riches AC
Stem Cells; 1997; 15(6):455-60. PubMed ID: 9402658
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of action of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) in the control of haematopoietic stem cell proliferation.
Robinson S; Lenfant M; Wdzieczak-Bakala J; Melville J; Riches A
Cell Prolif; 1992 Nov; 25(6):623-32. PubMed ID: 1457609
[TBL] [Abstract][Full Text] [Related]
4. In vivo modifications of AcSDKP metabolism and haematopoiesis in mice treated with 5-fluorouracil and Goralatide.
Comte L; Lorgeot V; Bignon J; Volkov L; Dupuis F; Wdzieczak-Bakala J; Praloran V
Eur J Clin Invest; 1998 Oct; 28(10):856-63. PubMed ID: 9793000
[TBL] [Abstract][Full Text] [Related]
5. In vitro effect of acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) analogs resistant to angiotensin I-converting enzyme on hematopoietic stem cell and progenitor cell proliferation.
Gaudron S; Grillon C; Thierry J; Riches A; Wierenga PK; Wdzieczak-Bakala J
Stem Cells; 1999; 17(2):100-6. PubMed ID: 10195570
[TBL] [Abstract][Full Text] [Related]
6. Activity of acetyl-n-ser-asp-lys-pro (AcSDKP) on hematopoietic progenitor cells in short-term and long-term murine bone marrow cultures.
Jackson JD; Yan Y; Ewel C; Talmadge JE
Exp Hematol; 1996 Feb; 24(3):475-81. PubMed ID: 8599978
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of analogues of the tetrapeptide N-Acetyl-Ser-Asp-Lys-Pro (AcSDKP), an inhibitor of primitive haematopoietic cell proliferation.
Thierry J; Grillon C; Gaudron S; Potier P; Riches A; Wdzieczak-Bakala J
J Pept Sci; 2001 May; 7(5):284-93. PubMed ID: 11428549
[TBL] [Abstract][Full Text] [Related]
8. In vivo assessment of captopril selectivity of angiotensin I-converting enzyme inhibition: differential inhibition of acetyl-ser-asp-lys-pro and angiotensin I hydrolysis.
Junot C; Menard J; Gonzales MF; Michaud A; Corvol P; Ezan E
J Pharmacol Exp Ther; 1999 Jun; 289(3):1257-61. PubMed ID: 10336514
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin I-converting enzyme and metabolism of the haematological peptide N-acetyl-seryl-aspartyl-lysyl-proline.
Azizi M; Junot C; Ezan E; Ménard J
Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1066-9. PubMed ID: 11903317
[TBL] [Abstract][Full Text] [Related]
10. Catabolism of the hemoregulatory peptide N-Acetyl-Ser-Asp-Lys-Pro: a new insight into the physiological role of the angiotensin-I-converting enzyme N-active site.
Rousseau-Plasse A; Lenfant M; Potier P
Bioorg Med Chem; 1996 Jul; 4(7):1113-9. PubMed ID: 8831983
[TBL] [Abstract][Full Text] [Related]
11. Captopril inhibits the proliferation of hematopoietic stem and progenitor cells in murine long-term bone marrow cultures.
Chisi JE; Wdzieczak-Bakala J; Thierry J; Briscoe CV; Riches AC
Stem Cells; 1999; 17(6):339-44. PubMed ID: 10606162
[TBL] [Abstract][Full Text] [Related]
12. Effect of angiotensin-converting enzyme inhibition on plasma, urine, and tissue concentrations of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro in rats.
Junot C; Nicolet L; Ezan E; Gonzales MF; Menard J; Azizi M
J Pharmacol Exp Ther; 1999 Dec; 291(3):982-7. PubMed ID: 10565814
[TBL] [Abstract][Full Text] [Related]
13. Activity of acetyl-Ser-Asp-Lys-Pro (AcSDKP) on human hematopoietic progenitor cells in short-term and long-term bone marrow cultures.
Jackson JD; Ozerol E; Yan Y; Ewel C; Talmadge JE
J Hematother Stem Cell Res; 2000 Aug; 9(4):489-96. PubMed ID: 10982247
[TBL] [Abstract][Full Text] [Related]
14. Lisinopril, an angiotensin I-converting enzyme inhibitor, prevents entry of murine hematopoietic stem cells into the cell cycle after irradiation in vivo.
Rousseau-Plasse A; Wdzieczak-Bakala J; Lenfant M; Ezan E; Genet R; Robinson S; Briscoe T; Melville J; Riches A
Exp Hematol; 1998 Oct; 26(11):1074-9. PubMed ID: 9766448
[TBL] [Abstract][Full Text] [Related]
15. The tetrapeptide AcSDKP, an inhibitor of the cell-cycle status for normal human hematopoietic progenitors, has no effect on leukemic cells.
Bonnet D; Césaire R; Lemoine F; Aoudjhane M; Najman A; Guigon M
Exp Hematol; 1992 Feb; 20(2):251-5. PubMed ID: 1544396
[TBL] [Abstract][Full Text] [Related]
16. Effects of the angiotensin-converting enzyme inhibitor enalapril on blood haematopoietic progenitors and acetyl-N-Ser-Asp-Lys-Pro concentrations.
Comte L; Lorgeot V; Volkov L; Allegraud A; Aldigier JC; Praloran V
Eur J Clin Invest; 1997 Sep; 27(9):788-90. PubMed ID: 9352252
[TBL] [Abstract][Full Text] [Related]
17. The tetrapeptide AcSDKP reduces the sensitivity of murine CFU-MK and CFU-GM progenitors to aracytine in vitro and in vivo.
Aidoudi S; Guigon M; Drouet V; Caen JP; Han ZC
Int J Hematol; 1998 Aug; 68(2):145-55. PubMed ID: 9803673
[TBL] [Abstract][Full Text] [Related]
18. The tetrapeptide AcSDKP specifically blocks the cycling of primitive normal but not leukemic progenitors in long-term culture: evidence for an indirect mechanism.
Cashman JD; Eaves AC; Eaves CJ
Blood; 1994 Sep; 84(5):1534-42. PubMed ID: 8068944
[TBL] [Abstract][Full Text] [Related]
19. Substrate dependence of angiotensin I-converting enzyme inhibition: captopril displays a partial selectivity for inhibition of N-acetyl-seryl-aspartyl-lysyl-proline hydrolysis compared with that of angiotensin I.
Michaud A; Williams TA; Chauvet MT; Corvol P
Mol Pharmacol; 1997 Jun; 51(6):1070-6. PubMed ID: 9187274
[TBL] [Abstract][Full Text] [Related]
20. In vivo haemoprotective activity of tetrapeptide AcSDKP combined with granulocyte-colony stimulating factor following sublethal irradiation.
Watanabe T; Kelsey LS; Yan Y; Brown GS; Jackson JD; Ewel C; Talmadge JE
Br J Haematol; 1996 Sep; 94(4):619-27. PubMed ID: 8826883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
